| Dr Tyler Holliday, MD | |
|
901 Harry S Truman Dr N, Largo, MD 20774-5477 | |
| (240) 667-2025 | |
| Not Available |
| Full Name | Dr Tyler Holliday |
|---|---|
| Gender | Male |
| Speciality | Surgery - Trauma Surgery |
| Location | 901 Harry S Truman Dr N, Largo, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699207654 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0127X | Surgery - Trauma Surgery | D0097603 (Maryland) | Primary |
| Entity Name | Shock Trauma Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679512909 PECOS PAC ID: 6800882317 Enrollment ID: O20040421000976 |
News Archive
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
A recent research letter published on the preprint server medRxiv in June 2020 evaluates the risk factors that may lead to higher mortality in pregnant women with COVID-19 in middle-income countries.
With more than 2,700 children having elevated blood lead levels in 2009, the Department of Health today reminds parents to test young children for lead exposure, especially during National Lead Poisoning Prevention Week, Oct. 24-30.
Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCRTM technology (MX ICE COLD-PCR).
Almost ten years ago, the group led by Erwin Wagner, currently at the Spanish National Cancer Research Centre (CNIO), developed genetically modified mice showing symptoms very reminiscent to psoriasis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tyler Holliday, MD 901 Harry S Truman Dr N, Largo, MD 20774-5477 Ph: (240) 677-2025 | Dr Tyler Holliday, MD 901 Harry S Truman Dr N, Largo, MD 20774-5477 Ph: (240) 667-2025 |
News Archive
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
A recent research letter published on the preprint server medRxiv in June 2020 evaluates the risk factors that may lead to higher mortality in pregnant women with COVID-19 in middle-income countries.
With more than 2,700 children having elevated blood lead levels in 2009, the Department of Health today reminds parents to test young children for lead exposure, especially during National Lead Poisoning Prevention Week, Oct. 24-30.
Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCRTM technology (MX ICE COLD-PCR).
Almost ten years ago, the group led by Erwin Wagner, currently at the Spanish National Cancer Research Centre (CNIO), developed genetically modified mice showing symptoms very reminiscent to psoriasis.
› Verified 4 days ago
Dr. Benjamin Daniel Powers, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 901 Harry Truman Dr N, Largo, MD 20774 Phone: 667-214-1718 Fax: 410-706-6976 | |
Dr. Nini Khozeimeh, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1221 Mercantile Ln, Kaiser Permanente Largo Medical Center, Largo, MD 20774 Phone: 301-618-5500 | |
Dr. Donna M Pittman, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1221 Mercantile Lane, Largo, MD 20774 Phone: 301-618-5638 Fax: 301-618-5673 |